CXCL-11

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCXCL-11
Drug Alias NameCXCL-11
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-X-C motif chemokine receptor 3 antagonists
TargetsC-X-C motif chemokine receptor 3
Therapy Area/IndicationsDiabetes Mellitus, Type 1Diabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRadikal Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRadikal Therapeutics
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 1Diabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A